Pfizer (PFE): Reassessing Valuation After Cautious 2026 Outlook and Fading COVID-19 Revenue [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
See our latest analysis for Pfizer. Even with today's dip on the 2026 guidance, Pfizer's 90 day share price return of 10.59% suggests sentiment has been quietly improving, while the 1 year total shareholder return of 12.25% hints that long term confidence is slowly rebuilding. If Pfizer's mixed outlook has you reassessing your healthcare exposure, this could be a good moment to explore other healthcare stocks that might offer a different balance of growth and stability. With shares still trading at a hefty intrinsic discount and analysts only penciling in modest upside, the key question now is whether Pfizer is a classic value opportunity or if the market has already priced in a muted recovery. With Pfizer closing at $26.43 versus a narrative fair value near $29, the most followed storyline still sees upside from today's reset expectations. Sustained shift of the portfolio toward high value biologics, innovative vaccines, and personalized therapies (including next generatio
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- FDA approves label change for Depo-Provera, adding brain tumor warning [MSNBC.com]MSNBC.com
- Pfizer CEO Defends Vaccines, Promises Growth by End of Decade [Yahoo! Finance]Yahoo! Finance
- Pfizer's modest 2026 outlook shows its big investments will take time to pay off [CNBC]CNBC
- Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know [Yahoo! Finance]Yahoo! Finance
- Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/16/25 - Form 8-K
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- PFE's page on the SEC website